Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (3y) (2012 - 2018)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (3y) (2012 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 10.53% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | -66.89% |
| Dec 31, 2017 | -7.77% |
| Sep 30, 2017 | -4.55% |
| Jun 30, 2017 | 60.12% |
| Mar 31, 2017 | -141.73% |
| Dec 31, 2016 | -66.19% |
| Sep 30, 2016 | -39.24% |
| Jun 30, 2016 | -1.55% |
| Mar 31, 2016 | -8.73% |
| Dec 31, 2015 | 7.41% |
| Sep 30, 2015 | 1.58% |
| Jun 30, 2015 | -3.63% |
| Mar 31, 2015 | -11.75% |
| Dec 31, 2014 | 3.08% |
| Sep 30, 2014 | -37.43% |
| Jun 30, 2014 | 23.38% |
| Mar 31, 2014 | 12.36% |
| Dec 31, 2013 | 40.52% |
| Sep 30, 2013 | 95.38% |
| Jun 30, 2013 | 27.17% |